• 한국식품영양과학회지
• /
• 제32권1호
• /
• pp.1-7
• /
• 2003

교역량이 증가되고 있는 수입 오렌지를 대상으로 radiation induced marker검색을 위하여, 방사선 조사시 예상되는 생물학적, 물리적 변화에 기초한 DNA comet assay, 열발광 (TL) 및 전자스핀공명 (ESR) 분석을 실시하였다. DNA comet assay 결과, 오렌지의 씨 및 과육의 cell은 감마선 조사와 무관하게 긴 tail을 가진 comet 모양으로 관찰되었으며, 저온 저장 6주까지도 유사한 경향이 유지되어 marker로의 활용 가능성이 낮았다. TL 측정 에서 비조사 시료는 약 200~30$0^{\circ}C$ 부근에서 매우 낮은 intensity의 glow curve를 나타내었고, 0.5 kGy 이상의 조사 시료에서는 조사 시료 특유의 peak가 18$0^{\circ}C$ 부근에서 나타났으며, 조사 선량의 증가에 따라 intensity 도 점차 증가하였다 TL 측정은 저장 6주까지도 가능하였고, TL ratio(TL$_1$/TL$_2$)의 산출은 검지 결과의 신뢰도를 높여주었다. ESR 측정에서는 시료의 씨, 과육 및 과피 부위에서 방사선 조사 유래의 특이적인 signal이 나타나지 않아 조사 시료와 비조사 시료의 구분이 불가능하였다. 이상의 결과에서 볼때 오렌지는 TL 분석에 의해 방사선 조사 여부의 확인이 가능하며 이 방법은 오렌지의 저온 상품성이 유지되는 저장6주 이후에도 적용이 가능한 것으로 나타났다.

• 한국유체기계학회 논문집
• /
• 제1권1호
• /
• pp.49-57
• /
• 1998

The acoustic signatures from a propeller fan under non-uniform inlet flow conditions were measured to reveal the mechanism for tonal radiation. Experimental studies were carried out by generating non-uniform turbulent flows with circumferential and radial components of harmonic incoming gust deliberately. This paper reports the measured acoustic power exponents and cross-spectra for circumferential and radial disturbances at a specified flow-rate coefficient.

• 환경생물
• /
• 제21권4호
• /
• pp.384-391
• /
• 2003

The induction of chromosome aberrations in Hordeum vulgare germs after irradiation is studied for the dose range of 10 to 1,000 mGy. The relationship between the frequency of aberrant cells and the absorbed dose is shown to be non -linear and has a dose-independent plateau within the range of 56-467 mGy where the level of cytogenetic damage is statistically significantly distinguished from the spontaneous level. The comparison of the goodness of the experimental data fitting with mathematical models of different complexities, using the most common quantitative criteria, demonstrates the benefit of the piecewise linear model over the linear and polynomial ones in approximating the cytogenetical disturbance frequency. The results of our study support the conclusion about indirect mechanism of chromosome aberrations induced by low doses or dose rates mutagenesis.

• 한국정밀공학회:학술대회논문집
• /
• 한국정밀공학회 2003년도 춘계학술대회 논문집
• /
• pp.569-572
• /
• 2003

In VLM-ST process, the fine detailed shape processing process is needed due to the use of thick sheets for layers. The developed process perform the fine detailed shape processing in VLM-ST parts using non-contact hot tool. To predict the heat-affected zone and temperature distribution of VLM-ST parts in detailed shaping, the heat flux from the tool to the surface was calculated for the finite element analysis by modeling the tool as a heat source of radiation. The dominant process parameters such as the radiated heat input, the tool speed, and the gap between the tool tip and the foam sheet (tool height) were considered in the analysis. The results showed a good agreement with the experiments.

• Nuclear Medicine and Molecular Imaging
• /
• 제42권sup1호
• /
• pp.17-28
• /
• 2008

This review focuses on the clinical use of $^{18}F-FDG$ PET to evaluate solitary pulmonary nodule (SPN) and non-small cell lung cancer (NSCLC). When SPN or mass without calcification is found on chest X-ray or CT, $^{18}F-FDG$ PET is an effective modality to differentiate benign from malignant lesions. For initial staging of NSCLC, $^{18}F-FDG$ PET is useful, and proved to be cost-effective in several countries. $^{18}F-FDG$ is useful for detecting recurrence, restaging and evaluating residual tumor after curative therapy in NSCLC. For therapy response assessment, $^{18}F-FDG$ PET may be effective after chemotherapy or radiation therapy. $^{18}F-FDG$ PET is useful to predict pathological response after neoadjuvant therapy in NSCLC. For radiation therapy planning, $^{18}F-FDG$ PET may be helpful, but requires further investigations. PET/CT is better for evaluating NSCLC than conventional PET.

• Radiation Oncology Journal
• /
• 제2권1호
• /
• pp.49-58
• /
• 1984

53 patients of previously untreated Stage I&II Non-Hodgkin's Lymphoma in head and neck treated with irradiation at Yonsei Cancer Center from January, 1970 to December, 1978 were retrospectively analysed. 5 year survival rate and 5 year disease free survival rate were $51.5\%\;and\;42\%$. Local control rate by irradiation was $92.4\%$ with mainly $4,000\~6,000$ rads. 21 patients suffered relapses after radiotherapy, 4 cases recurred within irradiated area, 4 cases at contiguous site of irradiation field, and 13 cases recurred at distant area, more commonly below diaphragm. Most cases relapsed within 1 year 6 months after treatment. Optimum irradiation field for head and neck localized lymphoma, prognostic factors ana usefulness of chemotherapy are also discussed.

• Nuclear Engineering and Technology
• /
• 제53권11호
• /
• pp.3491-3504
• /
• 2021

This paper reports on the state-of-the-art of the main non-destructive assay (NDA) techniques usually used for in-situ radiological characterization of nuclear facilities subject to a decommissioning programme. For the sake of clarity and coherence, they have been classified as environmental radiation monitoring, surface contamination measurements, gamma spectrometry, passive neutron counting and radiation cameras. Particular mention is also made here to the various challenges that each of these techniques must currently overcome, together with the formulation of some proposals for a potential evolution in the future.

• Radiation Oncology Journal
• /
• 제36권4호
• /
• pp.325-331
• /
• 2018

Purpose: Soft tissue sarcoma (STS) is a rare and heterogeneous cancer with over 50 known subtypes. It is difficult to understand the role of adjuvant treatment in STS. We aimed to determine the benefits of adjuvant treatment for a rare STS subset: non-extremity STS with moderate chemosensitivity. Materials and Methods: We reviewed medical records from Pusan National University Hospital and Kosin University Gospel Hospital, which had detailed pathological reports on patients diagnosed between 2006 and 2016. The most important inclusion criterion was resection with curative intent. We grouped STS by chemosensitivity based on reported data and analyzed non-extremity STS with moderate chemosensitivity. Results: We investigated 142 patients with 20 pathological subtypes of STS. Eighty-six patients had extremity STS and 56 had non-extremity STS. Thirty-eight of 56 patients were categorized as having moderate chemosensitivity. Seventeen of 38 patients (44.7%) received adjuvant radiotherapy and 14 (36.8%) received adjuvant chemotherapy. A log-rank test showed longer disease-free survival (DFS) in the adjuvant radiotherapy group than in the group treated without adjuvant radiotherapy (not reached vs. 1.468 years, p = 0.037). Multivariate Cox proportional hazard analysis, with covariates including age, stage, resection margin, adjuvant chemotherapy, and adjuvant radiotherapy, revealed that adjuvant radiotherapy was associated with longer DFS (odds ratio = 0.369, p = 0.045). Overall survival was not correlated with adjuvant radiotherapy. Conclusion: Adjuvant radiotherapy may be associated with longer DFS in patients with non-extremity STS with moderate chemosensitivity.

• Journal of Korean Neurosurgical Society
• /
• 제66권5호
• /
• pp.562-572
• /
• 2023

Objective : Bevacizumab is a feasible option for treating cerebral radiation necrosis (RN). We investigated the clinical outcome of RN after treatment with bevacizumab and factors related to the initial response and the sustained effect. Methods : Clinical data of 45 patients treated for symptomatic RN between September 2019 and February 2021 were retrospectively collected. Bevacizumab (7.5 mg/kg) was administered at 3-week intervals with a maximum four-cycle schedule. Changes in the lesions magnetic resonance image (MRI) scans were examined for the response evaluation. The subgroup analysis was performed based on the initial response and the long-term maintenance of the effect. Results : Of the 45 patients, 36 patients (80.0%) showed an initial response, and eight patients (17.8%) showed delayed worsening of the corresponding lesion. The non-responders showed a significantly higher incidence of diffusion restriction on MRI than the responders (100.0% vs. 25.0%, p<0.001). The delayed worsening group showed a significantly higher proportion of glioma pathology than the maintenance group (87.5% vs. 28.6%, p=0.005). Cumulative survival rates with sustained effect were significantly higher in the groups with non-glioma pathology (p=0.019) and the absence of diffusion restriction (p<0.001). Pathology of glioma and diffusion restriction in MRI were the independent risk factors for non-response or delayed worsening after initial response. Conclusion : The initial response of RN to bevacizumab was favorable, with improvement in four-fifths of the patients. However, a certain proportion of patients showed non-responsiveness or delayed exacerbations. Bevacizumab may be more effective in treating RN in patients with non-glioma pathology and without diffusion restriction in the MRI.

• Radiation Oncology Journal
• /
• 제24권4호
• /
• pp.237-242
• /
• 2006

목 적: 국소적으로 진행된 비소세포성 폐암에서 예후영향인자를 찾기 위하여 근치적 방사선 치료에 대한 성적을 후향적으로 평가하였다. 대상 및 방법: $1991{\sim}2002$년에 걸쳐 본원에서 방사선치료를 받은 stage IIIB 비소세포성 폐암 환자 216명의 의무기록을 후향적으로 분석하였다. 완전관해와 부분관해를 반응군(response group), 불변 및 진행성질환을 무반응군(non-response group)으로 묶어 분류하였다. 결 과: 근치목적의 방사선치료를 시행한 총 140명의 환자 중 방사선단독치료를 받은 환자는 68명, 항암화학제와 병용요법을 시행한 환자는 72명이었다. 계획된 방사선치료가 완료된 것은 단독에서는 30예, 병용요법에서는 39예였다. 중앙생존기간은 방사선 단독치료군에서는 4.6개월, 병용요법군에서는 9.9개월이었다. 1년, 2년 및 3년 생존율이 방사선 단독치료군에서는 13.3%, 3.3%, 0%였으며, 항암화학제 병용요법군에서는 각각 35.9%, 20.5%, 15.4%였다(p<0.001). 반응군에서 방사선 단독으로 치료한 환자는 중앙생존기간 7.2개월, 항암화학제 병용치료환자는 16.5개월이었고, 무반응군에서 단독치료 환자는 4.4개월, 병용치료환자는 6.7개월이었다(p=0.001). 치료반응과 항암화학요법의 병용이 전체생존율에 영향을 주었다(p<0.001). Grade 3 이상의 심한 합병증은 방사선 단독요법에서 2예(6.7%), 항암화학 병용요법에서 7예(17.9%)였다. 결 론: Stage IIIB 비소세포성 폐암에서 방사선치료와 더불어 항암화학치료를 병용했을 때, 방사선단독요법에 비해 치료반응률과 생존율이 더 높았다.